Schilder R - Search Results

1

Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid.

O'Dwyer PJ, LaCreta F, Nash S, Tinsley PW, Schilder R, Clapper ML, Tew KD, Panting L, Litwin S, Comis RL, et al. O'Dwyer PJ, et al. Among authors: schilder r. Cancer Res. 1991 Nov 15;51(22):6059-65. Cancer Res. 1991. PMID: 1933869 Clinical Trial.

2

Phase I and pharmacokinetic study of the novel platinum analogue CI-973 on a 5-daily dose schedule.

O'Dwyer PJ, Hudes GR, Walczak J, Schilder R, LaCreta F, Rogers B, Cohen I, Kowal C, Whitfield L, Boyd RA. O'Dwyer PJ, et al. Among authors: schilder r. Cancer Res. 1992 Dec 15;52(24):6746-53. Cancer Res. 1992. PMID: 1458462 Clinical Trial.

3

Phase II trial of PALA in combination with 5-fluorouracil in advanced pancreatic cancer.

Rosvold E, Schilder R, Walczak J, DiFino SM, Flynn PJ, Banerjee TK, Heim WJ, Engstrom PF, Ozols RF, O'Dwyer PJ. Rosvold E, et al. Among authors: schilder r. Cancer Chemother Pharmacol. 1992;29(4):305-8. doi: 10.1007/BF00685949. Cancer Chemother Pharmacol. 1992. PMID: 1537077 Clinical Trial.

4

Phase I trial of thiotepa in combination with recombinant human granulocyte-macrophage colony-stimulating factor.

O'Dwyer PJ, LaCreta FP, Schilder R, Nash S, McAleer C, Miller LL, Hudes GR, Ozols RF. O'Dwyer PJ, et al. Among authors: schilder r. J Clin Oncol. 1992 Aug;10(8):1352-8. doi: 10.1200/JCO.1992.10.8.1352. J Clin Oncol. 1992. PMID: 1634926 Clinical Trial.

5

Metallothionein gene expression and resistance to cisplatin in human ovarian cancer.

Schilder RJ, Hall L, Monks A, Handel LM, Fornace AJ Jr, Ozols RF, Fojo AT, Hamilton TC. Schilder RJ, et al. Int J Cancer. 1990 Mar 15;45(3):416-22. doi: 10.1002/ijc.2910450306. Int J Cancer. 1990. PMID: 2307530

6

Metabolic characterization of human non-Hodgkin's lymphomas in vivo with the use of proton-decoupled phosphorus magnetic resonance spectroscopy.

Negendank WG, Padavic-Shaller KA, Li CW, Murphy-Boesch J, Stoyanova R, Krigel RL, Schilder RJ, Smith MR, Brown TR. Negendank WG, et al. Among authors: schilder rj. Cancer Res. 1995 Aug 1;55(15):3286-94. Cancer Res. 1995. PMID: 7614463

7

Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule.

Schilder RJ, LaCreta FP, Perez RP, Johnson SW, Brennan JM, Rogatko A, Nash S, McAleer C, Hamilton TC, Roby D, et al. Schilder RJ, et al. Cancer Res. 1994 Feb 1;54(3):709-17. Cancer Res. 1994. PMID: 8306332 Clinical Trial.

8

Gynecological malignancies.

Schaebler DL, Schilder RJ, Young RC. Schaebler DL, et al. Among authors: schilder rj. Cancer Chemother Biol Response Modif. 1996;16:564-91. Cancer Chemother Biol Response Modif. 1996. PMID: 8639401 Review.

9

Phase I trial of ilmofosine as a 24 hour infusion weekly.

von Mehren M, Giantonio BJ, McAleer C, Schilder R, McPhillips J, O'Dwyer PJ. von Mehren M, et al. Among authors: schilder r. Invest New Drugs. 1995;13(3):205-10. doi: 10.1007/BF00873801. Invest New Drugs. 1995. PMID: 8729947 Clinical Trial.

10

A phase II trial of weekly infusional 5-fluorouracil in combination with low-dose leucovorin in patients with advanced colorectal cancer.

Haas NB, Schilder RJ, Nash S, Weiner LM, Catalano RC, Ozols RF, O'Dwyer PJ. Haas NB, et al. Among authors: schilder rj. Invest New Drugs. 1995;13(3):229-33. doi: 10.1007/BF00873805. Invest New Drugs. 1995. PMID: 8729951 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters